Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 EPIDERMILOGY
6 PESTEL ANALYSIS
7 PORTERS FIVE
8 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: REGULATORY FRAMEWORK
8.1 THE U.S. REGULATORY SCENARIO FOR KIRSTEN RAT SARCOMA (KRAS)
8.2 CANADA REGULATORY SCENARIO FOR KIRSTEN RAT SARCOMA (KRAS)
8.3 EUROPE REGULATORY GUIDANCE FOR KRISTEN RAT SARCOMA (KRAS)
8.4 JAPAN REGULATORY GUIDANCE FOR KIRSTEN RAT SARCOMA (KRAS)
8.5 AUSTRALIA REGULATORY SCENARIO FOR KIRSTEN RAT SARCOMA (KRAS)
9 MARKET OVERVIEW
9.1 DRIVERS
9.1.1 GROWING PREVALENCE OF CANCER
9.1.2 INCREASING R&D INVESTMENT
9.1.3 HIGH FREQUENCY OF KIRSTEN RAT SARCOMA (KRAS) MUTATION
9.2 RISING SHARE OF AGING POPULATION
9.2.1 PENETRATION OF NOVEL PRODUCTS
9.3 RESTRAINTS
9.3.1 HIGH COST OF PRODUCTS
9.3.2 PRODUCT RECALL IN RECENT PAST
9.3.3 LIMITATION OF KIRSTEN RAT SARCOMA (KRAS) MUTATION TESTING
9.3.4 ADVANCED LABORATORY REQUIREMENT
9.4 OPPORTUNITIES
9.4.1 INCREASING FUNDING FOR CANCER RESEARCH
9.4.2 COLLABORATION BETWEEN PHARMA AND DIAGNOSTIC COMPANIES
9.4.3 HIGH RISK OF KIRSTEN RAT SARCOMA (KRAS) MUTATION IN SPECIFIC POPULATION
9.5 CHALLENGES
9.5.1 LACK OF AWARENESS AND DEARTH OF EXPERTISE
9.5.2 HUGE UNMET MEDICAL NEED FOR KIRSTEN RAT SARCOMA (KRAS)
10 IMPACT OF COVID-19 ON THE EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET
10.1 IMPACT ON PRICE
10.2 IMPACT ON DEMAND
10.3 IMPACT OF SUPPLY
10.4 STRATEGIC DECISIONS BY MANUFACTURERS
10.5 CONCLUSION
11 EUROPE KIRSTEN RAT SARCOMA (KRAS) (KRAS) MARKET (KRAS) MARKET, BY PRODUCT
11.1 OVERVIEW
11.2 REAGENTS AND KITS
11.2.1 PCR TEST KITS
11.2.2 LIQUID BIOPSY PANELS
11.2.3 KRAS MONOCLONAL ANTIBODY
11.2.4 OTHERS
11.3 ANALYZERS
11.4 CONSUMABLES
11.5 CAPILLARY ELECTROPHORESIS POLYMERS
11.6 COLUMNS
11.7 BUFFERS
11.8 ENZYMES
11.9 DNA SIZE MARKER
11.1 MAGNET PLATES
11.11 COLLECTION TUBES
11.12 OTHERS
12 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE
12.1 OVERVIEW
12.2 LUNG CANCER
12.3 COLORECTAL CANCER
12.4 PANCREATIC CANCER
12.5 BREAST CANCER
12.6 PROSTATE CANCER
12.7 CERVICAL CANCER
12.8 SKIN CANCER
12.9 KIDNEY CANCER
12.1 BLOOD CANCER
12.11 OTHERS
13 EUROPE KIRSTEN RAT SARCOMA (KRAS) (KRAS) MARKET (KRAS)TREATMENT MARKET, BY AGE GROUP
13.1 OVERVIEW
13.2 ADULTS
13.3 PEDIATRIC
14 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 DISEASE DIAGNOSTICS
14.3 PREDICTIVE
14.4 DRUG DISCOVERY AND DEVELOPMENT
14.5 THERAPEUTIC APPROACH OR PROGNOSTICS
14.6 DEVELOPMENT OF MOLECULAR DIAGNOSTICS
14.7 RESEARCH AND DEVELOPMENT
14.8 PERSONALISED MEDICINE
14.9 OTHERS
15 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER
15.1 OVERVIEW
15.2 DIAGNOSTIC LABORATORIES
15.3 HOSPITALS
15.4 PHARMA AND BIOTECH COMPANIES
15.5 ONCOLOGY SPECIALITY CLINICS
15.6 ACADEMIC AND CANCER RESEARCH INSTITUTES
15.7 OTHERS
16 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 THIRD PARTY DISTRIBUTOR
17 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET BY COUNTRY
17.1 EUROPE
17.1.1 GERMANY
17.1.2 FRANCE
17.1.3 U.K.
17.1.4 ITALY
17.1.5 RUSSIA
17.1.6 SPAIN
17.1.7 SWITZERLAND
17.1.8 NETHERLANDS
17.1.9 TURKEY
17.1.10 BELGIUM
17.1.11 REST OF EUROPE
18 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: EUROPE
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 THERMO FISHER SCIENTIFIC INC.
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE FINANCIALS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENTS
20.2 F.HOFFMANN-LA ROCHE LTD
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.3 BIOCARTIS
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE FINANCIALS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENTS
20.4 ILLUMINA, INC
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE FINANCIALS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENTS
20.5 MERCK KGAA
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 0PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENTS
20.6 ABBOTT
20.6.1 COMPANY SNAPSHOT
20.6.2 REVENUE ANALYSIS
20.6.3 PRODUCT PORTFOLIO
20.6.4 RECENT DEVELOPMENT
20.7 QIAGEN
20.7.1 COMPANY SNAPSHOT
20.7.2 REVENUE ANALYSIS
20.7.3 PRODUCT PORTFOLIO
20.7.4 RECENT DEVELOPMENT
20.8 ALIGENT TECHNOLOGIES, INC.
20.8.1 COMPANY SNAPSHOT
20.8.2 REVENUE ANALYSIS
20.8.3 PRODUCT PORTFOLIO
20.8.4 RECENT DEVELOPMENTS
20.9 AMOY DIAGNOSTICS CO., LTD.
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT S
20.1 AGENA BIOSCIENCES, INC
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENTS
20.11 BIOTYPE GMBH
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 CENTOGENE N.V.
20.12.1 COMPANY SNAPSHOT
20.12.2 REVENUE ANALYSIS
20.12.3 PRODUCT PORTFOLIO
20.12.4 RECENT DEVELOPMENTS
20.13 DIACARTA
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENTS
20.14 ENTROGEN, INC.
20.14.1 COMPANY SNAPSHOT
20.14.2 PRODUCT PORTFOLIO
20.14.3 RECENT DEVELOPMENTS
20.15 MIRADX
20.15.1 COMPANY SNAPSHOT
20.15.2 PRODUCT PORTFOLIO
20.15.3 RECENT DEVELOPMENT
20.16 PANAGENE
20.16.1 COMPANY SNAPSHOT
20.16.2 PRODUCT PORTFOLIO
20.16.3 RECENT DEVELOPMENTS
20.17 PROTEINTECH GROUP, INC
20.17.1 COMPANY SNAPSHOT
20.17.2 PRODUCT PORTFOLIO
20.17.3 RECENT DEVELOPMENTS
20.18 SYSMEX INOSTICS
20.18.1 COMPANY SNAPSHOT
20.18.2 PRODUCT PORTFOLIO
20.18.3 RECENT DEVELOPMENTS
20.19 TAKARA BIO, INC
20.19.1 COMPANY SNAPSHOT
20.19.2 REVENUE FINANCIALS
20.19.3 PRODUCT PORTFOLIO
20.19.4 RECENT DEVELOPMENTS
20.2 VIENNALAB DIAGNOSTICS GMBH
20.20.1 COMPANY SNAPSHOT
20.20.2 PRODUCT PORTFOLIO
20.20.3 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 BELOW MENTIONED TABLE SHOWS THE PRICE OF KIRSTEN RAT SARCOMA (KRAS) ANTIBODIES AND VARIOUS OTHER DETECTION KITS THAT ARE SUPPLIED BY MAJOR MARKET PLAYERS:
TABLE 2 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 3 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 4 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 5 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 6 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 7 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 8 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 9 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 10 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET, COUNTRY, 2019-2028 (USD MILLION)
TABLE 11 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 12 EUROPE REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 13 EUROPE CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 14 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 15 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 16 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 17 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 18 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 19 GERMANY KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 20 GERMANY REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 21 GERMANY CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 22 GERMANY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 23 GERMANY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 24 GERMANY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 25 GERMANY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 26 GERMANY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 27 FRANCE KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 28 FRANCE REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 29 FRANCE CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 30 FRANCE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 31 FRANCE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 32 FRANCE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 33 FRANCE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 34 FRANCE KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 35 U.K. KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 36 U.K. REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 37 U.K. CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 38 U.K. KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 39 U.K. KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 40 U.K. KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 41 U.K. KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 42 U.K. KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 43 ITALY KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 44 ITALY REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 45 ITALY CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 46 ITALY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 47 ITALY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 48 ITALY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 49 ITALY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 50 ITALY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 51 RUSSIA KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 52 RUSSIA REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 53 RUSSIA CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 54 RUSSIA KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 55 RUSSIA KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 56 RUSSIA KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 57 RUSSIA KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 58 RUSSIA KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 59 SPAIN KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 60 SPAIN REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 61 SPAIN CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 62 SPAIN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 63 SPAIN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 64 SPAIN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 65 SPAIN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 66 SPAIN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 67 SWITZERLAND KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 68 SWITZERLAND REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 69 SWITZERLAND CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 70 SWITZERLAND KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 71 SWITZERLAND KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 72 SWITZERLAND KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 73 SWITZERLAND KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 74 SWITZERLAND KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 75 NETHERLANDS KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 76 NETHERLANDS REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 77 NETHERLANDS CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 78 NETHERLANDS KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 79 NETHERLANDS KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 80 NETHERLANDS KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 81 NETHERLANDS KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 82 NETHERLANDS KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 83 TURKEY KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 84 TURKEY REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 85 TURKEY CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 86 TURKEY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 87 TURKEY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 88 TURKEY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 89 TURKEY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 90 TURKEY KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 91 BELGIUM KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
TABLE 92 BELGIUM REAGENTS & KITS IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 93 BELGIUM CONSUMABLES IN KIRSTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT 2019-2028 (USD MILLION)
TABLE 94 BELGIUM KIRSTEN RAT SARCOMA (KRAS) MARKET, BY CANCER TYPE 2019-2028 (USD MILLION)
TABLE 95 BELGIUM KIRSTEN RAT SARCOMA (KRAS) MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
TABLE 96 BELGIUM KIRSTEN RAT SARCOMA (KRAS) MARKET, BY APPLICATION 2019-2028 (USD MILLION)
TABLE 97 BELGIUM KIRSTEN RAT SARCOMA (KRAS) MARKET, BY END USER 2019-2028 (USD MILLION)
TABLE 98 BELGIUM KIRSTEN RAT SARCOMA (KRAS) MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 99 REST OF EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET, BY PRODUCT, 2019-2028 (USD MILLION )
List of Figure
LIST OF FIGURES
FIGURE 1 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: SEGMENTATION
FIGURE 2 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: DROC ANALYSIS
FIGURE 4 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF CANCER ASSOCIATED WITH KRAS MUTATION WORLDWIDE, INCREASED INVESTMENT IN R&D AND PENETRATION OF NOVEL KRAS DIAGNOSTIC PRODUCTS IS EXPECTED TO DRIVE THE EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 REAGENTS & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET AND IS ALSO EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 EUROPE KIRSTEN RAT SARCOMA (KRAS) MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET
FIGURE 16 NUMBER OF NEW CANCER CASES IN 2018 FOR ALL AGES
FIGURE 17 BELOW CHART SHOWS THE PREVALENCE OF PANCREATIC CANCER IN THE U.S. REGION FROM 2003-2017:
FIGURE 18 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY PRODUCT, 2020
FIGURE 19 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY PRODUCT, 2020-2028 (USD MILLION)
FIGURE 20 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 21 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 22 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY CANCER TYPE, 2020
FIGURE 23 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY CANCER TYPE , 2020-2028 (USD MILLION)
FIGURE 24 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY CANCER TYPE, CAGR (2021-2028)
FIGURE 25 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY CANCER TYPE, LIFELINE CURVE
FIGURE 26 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY AGE GROUP, 2020
FIGURE 27 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY AGE GROUP 2020-2028 (USD MILLION)
FIGURE 28 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKETT: BY AGE GROUP, CAGR (2021-2028)
FIGURE 29 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 30 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY APPLICATION, 2020
FIGURE 31 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY APPLICATION 2020-2028 (USD MILLION)
FIGURE 32 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 33 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY END USER, 2020
FIGURE 35 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY END USER 2020-2028 (USD MILLION)
FIGURE 36 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY END USER, CAGR (2021-2028)
FIGURE 37 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 39 EUROPE KIRSTEN RAT SARCOMA (KRAS)MARKET: BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
FIGURE 40 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 41 EUROPE KIRSTEN RAT SARCOMA (KRAS) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET: SNAPSHOT (2020)
FIGURE 43 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET: BY COUNTRY (2020)
FIGURE 44 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET: BY COUNTRY (2021 & 2028
FIGURE 45 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 47 EUROPE KRISTEN RAT SARCOMA (KRAS) MARKET: COMPANY SHARE 2020 (%)
